Indian pharma stocks fall as Trump moves to cut U.S. drug prices

Indian pharma stocks fall as Trump moves to cut U.S. drug prices

A view of the Sun Pharma office. File | Photo Credit: Reuters Indian pharma stocks fell 1.6% on Monday (May 12, 2025), bucking broader market gains, after U.S. President Donald Trump said he would cut drug prices by 30%–80% to match other wealthy nations. Mr. Trump said he would sign an executive order on Monday […]

Continue Reading
Sun Pharma reports Q4 net loss at ₹2,277 cr

Sun Pharma reports Q4 net loss at ₹2,277 cr

Sun Pharmaceutical Industries on Monday said its consolidated net loss stood at ₹2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss. The Mumbai-based drug major had reported a net profit of ₹894 crore in the January-March period of 2020-21. Consolidated sales from operations stood at ₹9,386 crore […]

Continue Reading